178 results on '"Toupance, Olivier"'
Search Results
2. Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
3. Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial
4. Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients
5. A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil
6. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation1
7. INTERSTITIAL FIBROSIS/TUBULAR ATROPHY (IF/TA) ACCORDING TO EPITHELIAL-MESENCHYMAL TRANSITION (EMT) PROFILE: PRELIMINARY RESULTS OF THE CERTITEM TRIAL: O43-0025
8. THREE-YEAR SAFETY AND EFFICACY OUTCOMES IN KIDNEY TRANSPLANT PATIENTS RANDOMIZED TO STEROID AVOIDANCE OR MAINTENANCE STEROIDS WITH EARLY INTENSIFIED DOSING OF ENTERICCOATED MYCOPHENOLATE SODIUM: THE INFINITY STUDY: O13-0034
9. MINIMIZATION OF MAINTENANCE IMMUNOSUPPRESSION IN RENAL TRANSPLANTATION: 10 YEAR RESULTS OF A RANDOMIZED STUDY COMPARING CYCLOSPORINE A MONOTHERAPY TO BITHERAPY WITH CICLOSPORINE A-MMF OR CICLOSPORINE-AZA: O10-0047
10. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses
11. Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients
12. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation
13. Outbreak of pneumocystis pneumonia occurring in late post-transplantation period
14. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
15. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits
16. FINAL RESULTS OF PRETRANSPLANT PHARMACOGENETIC ADAPTATION OF TACROLIMUS (TAC) TREATMENT AFTER RENAL TRANSPLANTATION: O-253
17. Poster Board #-Session: P123-II Impact of Interstitial Fibrosis (IF) by Automatic Quantification at One Year on the Evolution of Renal Function in Transplant Recipients with Cyclosporine Discontinuation and Sirolimus Introduction.: Abstract# 1103
18. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A
19. Effect of the shipment of cadaveric renal allografts on allograft survival
20. Interindividual variability in the concentration–effect relationship of antilymphocyte globulins—a possible influence of FcγRIIIa genetic polymorphism
21. CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients
22. Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients
23. Sirolimus-Induced Thrombotic Microangiopathy is Associated with Decreased Expression of Vascular Endothelial Growth Factor in Kidneys
24. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients
25. Evidence that Clearance of Hepatitis C Virus RNA after α-Interferon Therapy in Dialysis Patients Is Sustained after Renal Transplantation
26. Reversible abnormal chromatin clumping in granulocytes from six transplant patients treated with mycophenolate mofetil: a rare adverse effect mimicking abnormal chromatin clumping syndrome
27. Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
28. Acyclovir To Prevent Cytomegalovirus Infection after Renal Transplantation
29. PHENOTYPIC STUDY OF KIDNEY TRANSPLANT PATIENTS PRESENTING DE NOVO DSA: A FRENCH MULTICENTER COHORT OF 96 CASES
30. Prevention of vascular thrombosis by human purified protein C concentrate in a patient with familial PC deficiency undergoing renal transplantation
31. Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A
32. One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation
33. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
34. 0339: Does mineralocorticoid receptor antoganism could alleviate cyclosporin-induced nephrotoxicity in renal transplant recipients?
35. Microbiological Diagnosis of Severe Diarrhea in Kidney Transplant Recipients by Use of Multiplex PCR Assays
36. Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score
37. Efficacité mais effets secondaires d’un traitement par anakinra pour goutte chronique réfractaire chez une patiente greffée rénale en insuffisance rénale chronique pré-terminale
38. Efficacy but side effects of anakinra therapy for chronic refractory gout in a renal transplant recipient with preterminal chronic renal failure
39. Encéphalomyélites aiguës disséminées chez deux greffés rénaux
40. Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy
41. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation
42. Evaluation of Sample Bias for Measuring Plasma Iohexol Clearance in Kidney Transplantation
43. Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus
44. Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status
45. Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting Periods
46. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1
47. Conservative treatment of primary gastric B-cell lymphoma of MALT-type arising in the setting of HIV infection and posttransplantation
48. Virological and Histological Responses to One Year Alpha-Interferon-2a in Hemodialyzed Patients with Chronic Hepatitis C
49. FACTORS PREDICTING THE LONG-TERM SUCCESS OF MAINTENANCE CYCLOSPORINE MONOTHERAPY AFTER KIDNEY TRANSPLANTATION1
50. STEROID WITHDRAWAL IN CICLOSPORIN PLUS MYCOPHENOLATE MOFETIL TREATED RENAL ALLOGRAFT RECIPIENTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.